• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

母胎医学会特别声明:对产后再入院率作为质量指标的批评。

Society for Maternal-Fetal Medicine Special Statement: A critique of postpartum readmission rate as a quality metric.

出版信息

Am J Obstet Gynecol. 2022 Apr;226(4):B2-B9. doi: 10.1016/j.ajog.2021.11.1355. Epub 2021 Nov 25.

DOI:10.1016/j.ajog.2021.11.1355
PMID:34838802
Abstract

Hospital readmission is considered a core measure of quality in healthcare. Readmission soon after hospital discharge can result from suboptimal care during the index hospitalization or from inadequate systems for postdischarge care. For many conditions, readmission is associated with a high rate of serious morbidity and potentially avoidable costs. In obstetrics, for postpartum care specifically, hospitals and payers can easily track the rate of maternal readmission after childbirth and may seek to incentivize obstetricians, maternal-fetal medicine specialists, or provider groups to reduce the rate of readmission. However, this practice has not been shown to improve outcomes or reduce harm. There are major concerns with incentivizing providers to reduce postpartum readmissions, including the lack of a standardized metric, a baseline rate of 1% to 2% that is too low to accurately discriminate between random variation and controllable factors, the need for risk adjustment that greatly complicates rate calculations, the potential for bias depending on the duration of the follow-up interval, the potential for the "gaming" of the metric, the lack of evidence that obstetrical providers can influence the rate, and the potential for unintended harm in the vulnerable postpartum population. Until these problems are adequately addressed, maternal readmission rate after a childbirth hospitalization currently has limited utility as a metric for quality or performance improvement or as a factor to adjust provider reimbursement.

摘要

医院再入院被认为是医疗保健质量的核心衡量标准。出院后不久再次入院可能是由于指数住院期间护理不佳,也可能是由于出院后护理系统不完善。对于许多疾病,再入院与严重发病率和潜在可避免的成本高度相关。在产科,特别是产后护理方面,医院和支付方可以轻松跟踪产妇分娩后再次入院的比率,并可能试图激励妇产科医生、母胎医学专家或医疗服务提供者团体降低再入院率。然而,这种做法并没有显示出能改善结果或减少伤害。激励提供者降低产后再入院率存在重大问题,包括缺乏标准化指标、1%至 2%的基线率太低,无法准确区分随机变化和可控因素、需要风险调整,这极大地复杂化了比率计算、潜在的基于随访间隔时间的偏差、指标“操纵”的可能性、缺乏证据表明产科提供者可以影响该比率,以及脆弱的产后人群中潜在的意外伤害。在这些问题得到充分解决之前,分娩后住院患者的再入院率作为衡量质量或绩效改进的指标,或作为调整提供者报销的因素,其用途有限。

相似文献

1
Society for Maternal-Fetal Medicine Special Statement: A critique of postpartum readmission rate as a quality metric.母胎医学会特别声明:对产后再入院率作为质量指标的批评。
Am J Obstet Gynecol. 2022 Apr;226(4):B2-B9. doi: 10.1016/j.ajog.2021.11.1355. Epub 2021 Nov 25.
2
Society for Maternal-Fetal Medicine Special Statement: Quality metric for timely postpartum follow-up after severe hypertension.母胎医学会特别声明:严重高血压产后及时随访的质量指标。
Am J Obstet Gynecol. 2022 Sep;227(3):B2-B8. doi: 10.1016/j.ajog.2022.05.045. Epub 2022 May 27.
3
Risk factors for postpartum maternal mortality and hospital readmission in low- and middle-income countries: a systematic review.中低收入国家产后产妇死亡和医院再入院的风险因素:系统评价。
BMC Pregnancy Childbirth. 2023 Apr 29;23(1):303. doi: 10.1186/s12884-023-05459-y.
4
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
5
Postpartum readmissions among women with opioid use disorder.产后阿片类药物使用障碍女性的再入院情况。
Am J Obstet Gynecol MFM. 2019 Mar;1(1):89-98. doi: 10.1016/j.ajogmf.2019.02.004. Epub 2019 Mar 6.
6
A multi-state analysis of postpartum readmissions in the United States.美国产后再入院的多州分析。
Am J Obstet Gynecol. 2016 Jul;215(1):113.e1-113.e10. doi: 10.1016/j.ajog.2016.01.174.
7
Society for Maternal-Fetal Medicine Special Statement: Clinical quality measures in obstetrics.母胎医学会特别声明:产科临床质量指标
Am J Obstet Gynecol. 2024 Mar;230(3):B2-B17. doi: 10.1016/j.ajog.2023.11.011. Epub 2023 Nov 7.
8
Postpartum readmission and uninsurance at readmission for Medicaid vs privately insured births.产后再入院情况以及医疗补助计划覆盖分娩与私人保险分娩再入院时的未参保情况
Am J Obstet Gynecol MFM. 2022 Mar;4(2):100553. doi: 10.1016/j.ajogmf.2021.100553. Epub 2021 Dec 14.
9
Risk for postpartum readmissions and associated complications based on maternal age.基于产妇年龄的产后再入院风险和相关并发症。
J Matern Fetal Neonatal Med. 2021 May;34(9):1375-1381. doi: 10.1080/14767058.2019.1637411. Epub 2019 Jul 4.
10
Preventing readmissions through comprehensive discharge planning.通过全面的出院计划预防再入院。
Prof Case Manag. 2013 Mar-Apr;18(2):56-63; quiz 64-5. doi: 10.1097/NCM.0b013e31827de1ce.

引用本文的文献

1
Risk factors for postpartum readmission: a prediction model in Iranian pregnant women.产后再入院的风险因素:伊朗孕妇的预测模型。
BMC Pregnancy Childbirth. 2024 Jul 6;24(1):466. doi: 10.1186/s12884-024-06663-0.
2
Trends in racial/ethnic disparities in postpartum hospital readmissions in California from 1997 to 2018.1997年至2018年加利福尼亚州产后医院再入院的种族/族裔差异趋势。
AJOG Glob Rep. 2024 Mar 10;4(2):100331. doi: 10.1016/j.xagr.2024.100331. eCollection 2024 May.
3
Inpatient midwifery staffing levels and postpartum readmissions: a retrospective multicentre longitudinal study.
住院助产士人员配备水平与产后再入院:一项回顾性多中心纵向研究。
BMJ Open. 2024 Apr 3;14(4):e077710. doi: 10.1136/bmjopen-2023-077710.
4
Association of Neighborhood Socioeconomic Disadvantage and Postpartum Readmission.社区社会经济劣势与产后再入院的关联。
Obstet Gynecol. 2023 May 1;141(5):967-970. doi: 10.1097/AOG.0000000000005151. Epub 2023 Apr 5.
5
Postpartum Hospital Readmissions With and Without Severe Maternal Morbidity Within 1 Year of Birth, Oregon, 2012-2017.2012-2017 年俄勒冈州产后 1 年内有无严重产妇病状的住院再入院情况。
Am J Epidemiol. 2023 Feb 1;192(2):158-170. doi: 10.1093/aje/kwac183.
6
Postpartum readmissions for hypertensive disorders in pregnancy during the COVID-19 pandemic.2019冠状病毒病大流行期间妊娠高血压疾病的产后再入院情况。
AJOG Glob Rep. 2022 Nov;2(4):100108. doi: 10.1016/j.xagr.2022.100108. Epub 2022 Sep 22.